Stay updated on Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T08:50:01.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:47:54.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:48:25.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of a clinical study on metastatic breast cancer, including a change in the principal investigator and the addition of specific treatment details. The study now emphasizes the use of Pembrolizumab in combination with HER2 Bispecific Antibody Armed Activated T-Cell infusions.
    Difference
    45%
    Check dated 2025-04-16T01:35:33.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:06:23.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.2 to v2.14.3 and changed the date from November 2024 to March 2025.
    Difference
    0.4%
    Check dated 2025-04-01T13:49:32.000Z thumbnail image

Stay in the know with updates to Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.